Surf Bio

Surf Bio is a preclinical biopharmaceutical company leveraging a breakthrough next-generation surfactant to develop enhanced therapeutic solutions for diabetes, oncology, infectious diseases, gene therapy, and other therapeutic areas.

Surf Bio headquartered in United States, North America, operates in the Biotechnology, Pharmaceutical, Therapeutics, Oncology sector. The company focuses on Biotechnology and has secured $563.2M in funding across 32 round(s). With a team of 1-10 employees, Surf Bio is actively contributing to advancements in Biotechnology. Their latest funding round, Grant - Surf Bio, raised $1.6M. Discover more about their projects, partnerships, and impact on our platform.